Influence of hypoxia‑related genetic polymorphisms on the prognosis of patients with metastatic gastric cancer treated with EOF

Wenbo Tang(Chinese PLA General Hospital), Zhiyu Chen(Chongqing University), Xin Liu(Kunming Medical University), Jin Li(Xihua University), Mingzhu Huang(Shanghai Medical College of Fudan University), Jiliang Yin(Shanghai Medical College of Fudan University), Xiaoying Zhao(Handan College), Weijian Guo(Fudan University Shanghai Cancer Center), Xiaodong Zhu(Fudan University Shanghai Cancer Center), Li‐Xin Qiu(Fudan University Shanghai Cancer Center)
Oncology Letters
November 15, 2017
10.3892/ol.2017.7414
Cited by 2

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2013|247
Addressing MRSA infection and antibacterial resistance with peptoid polymers
|Nature Communications|2021|210
Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis
|BMC Cancer|2014|146